Karyopharm Therapeutics Inc (KPTI) Has Risen 3.77%, Becoming A Winning Stock For Investors
Karyopharm Therapeutics Inc (NASDAQ:KPTI) has a beta value of 0.13 and has seen 1.01 million shares traded in the last trading session. The company, currently